Infectious Disease Therapeutics Market Size and Share by 2031
The infectious disease therapeutics market size in 2022 stood at US$ 1,19,708.77 million and is projected to reach US$ 1,67,883.93 million by 2030. The market is expected to register a CAGR of 4.30% during 2022–2030. Rising number of product approvals and launches is likely to remain key trends in the market.
Infectious Disease Therapeutics Market Analysis
The rising prevalence of infectious diseases in society, the market players have released advanced medicines for the treatment of infectious disorders, the initiatives taken by the government to provide individuals with sophisticated facilities for the treatment of infectious diseases is driving the market.
Infectious Disease Therapeutics Market Overview
Bacteria, viruses, fungus, and parasites are all creatures that cause infectious diseases. Antibiotics, antivirals, and antiparasitics are some of the medications used to treat infectious disorders. Therapeutics for infectious diseases could act directly on organisms or aid the body's immune system in fighting infections. Infectious diseases include HIV, tuberculosis, malaria, hepatitis, and influenza, among others.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Infectious Disease Therapeutics Market: Strategic Insights
Market Size Value in US$ 1,19,708.77 million in 2022 Market Size Value by US$ 1,67,883.93 million by 2030 Growth rate CAGR of 4.30% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Infectious Disease Therapeutics Market: Strategic Insights
| Market Size Value in | US$ 1,19,708.77 million in 2022 |
| Market Size Value by | US$ 1,67,883.93 million by 2030 |
| Growth rate | CAGR of 4.30% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Infectious Disease Therapeutics Market Drivers and Opportunities
Increasing Focus on Funding and R&D in Infectious Disease Therapeutics to Favor Market Growth
Research and development (R&D) is a important part of the business of pharmaceutical companies and biopharmaceuticals. R&D allows the companies to launch new products for several therapeutic applications with significant medical and commercial potential. Also, leading market players are investing in R&D to develop enhanced technologies and gain more revenue share.
The table below displays the annual funding for various disease categories and research on the basis of contracts, grants, and other funding mechanisms used across the National Institutes of Health (NIH).
Diseases and Funding
Disease/Research Areas | 2019 (US$ Millions) | 2020 (US$ Millions) | 2021 (US$ Millions) | 2022 (US$ Millions) |
Emerging Infectious Diseases | 2,950 | 4,867 | 5,069 | 4,318 |
Infectious Diseases | 6,313 | 8,301 | 8,599 | 8,019 |
Sexually Transmitted Infections | 354 | 394 | 404 | 419 |
Note: Current conversion rate is considered for the currencies.
Source: Annual Reports and The Insight Partners Analysis
The major projects that the manufacturers have funded:
• In June 2022, GSK plc invested US$ 1.21 billion (£1 billion) over 10 years to expedite research and development (R&D) focused on infectious diseases that disproportionately affect low-income nations. The research will concentrate on new medicines and disruptive vaccines to prevent and treat malaria, tuberculosis, HIV (via ViiV Healthcare), neglected tropical diseases (NTDs), and anti-microbial resistance (AMR).
• In March 2022, the Global Fund's COVID-19 Response Mechanism (C19RM) received a donation of US$ 48.07 million (CAD 60 million) from Canada which was praised by the Global Fund to Fight AIDS, Tuberculosis, and Malaria. The new funds was used to offer low- and middle-income countries with vital treatments and diagnostic tests, including medical oxygen, and personal protective equipment (PPE).
Thus, rising focus on R&D and funding is driving the infectious disease therapeutics market growth.
Growing Opportunities in Developing Nations
The rising prevalence of infectious diseases is anticipated to improve sales of infectious disease treatment medications in emerging countries. Because of the lower data requirements and stricter laws, Asia Pacific has emerged as a flexible and business-friendly region. Furthermore, large investments in health research and life science in emerging countries play an important role in supporting cutting-edge technology in developing countries, which in turn encourages the trend towards infectious disease detection and treatment. For example, UNAIDS is calling for a US$ 29 billion investment by 2025 to satisfy the AIDS prevention and treatment needs of low- and middle-income countries. In India, South Korea, Brazil, and Mexico, infectious diseases such as Hepatitis, HAI, HIV, and influenza are prevalent; there is a big patient population; disposable money has increased; healthcare infrastructure has improved; and medical tourism is expanding. Thus, essential infectious disease therapeutics product producers in expanding infectious disease therapeutics markets in these nations should expect profitable prospects in the future.
Infectious Disease Therapeutics Market Report Segmentation Analysis
Key segments that contributed to the derivation of the infectious disease therapeutics market analysis are drug class, indication, route of administration, distribution channel.
- Based on drug class, the infectious disease therapeutics market is divided into anti-viral, anti-bacterial, anti-fungal, and others. The anti-viral segment held the largest market share in 2022.
- By indication, the market is segmented into HIV, hepatitis, tuberculosis, influenza, HPV, and others. The HIV segment held the largest share of the market in 2022.
- In terms of route of administration, the market is segmented into a oral, parenteral, topical, and others. The oral manufacturers segment held the largest share of the market in 2022.
- Based on distribution channel, the infectious disease therapeutics market is divided into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment held the largest market share in 2022.
Infectious Disease Therapeutics Market Share Analysis by Geography
The geographic scope of the infectious disease therapeutics market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
North America has dominated the market. Growing adoption of technological advancements and rising research and development activities are projected to accelerate the growth of the infectious disease therapeutics market. Moreover, large healthcare businesses and the rising demand for advanced therapeutic solutions to treat chronic conditions and viral diseases are propelling the market expansion in this region.
Infectious Disease Therapeutics Market Report Scope
Infectious Disease Therapeutics Market News and Recent Developments
The infectious disease therapeutics market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the infectious disease therapeutics market are listed below:
- Roche launched the first infectious disease tests and cobas omni–Utility Channel for use on the cobas 5800 System in countries accepting the CE Mark. The cobas omni–Utility Channel on the cobas 5800 System enables a broader testing menu by consolidating open channel assays with Roche in vitro diagnostic (IVD) assays on a single platform. (Source: F. Hoffmann-La Roche Ltd, Press Release, December 2022)
Infectious Disease Therapeutics Market Report Coverage and Deliverables
The “Infectious Disease Therapeutics Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:
- Infectious disease therapeutics market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Infectious disease therapeutics market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- infectious disease therapeutics market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the infectious disease therapeutics market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Drug Class, Indication, Route of Administration, Distribution Channel
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The market is estimated to grow at a CAGR of 4.5% during 2023–2031.
Rising prevalence of infectious disease and increasing focus on funding and R&D for infectious disease therapeutics are the factors driving the market.
The estimated value of the market by 2031 will be US$ 176.17 billion.
Rising number of product approvals and launches is likely to act as future trends in the market.
Pfizer Inc, Gilead Sciences Inc, F. Hoffmann-La Roche Ltd, Shionogi & Co Ltd, Bayer AG, BioCryst Pharmaceuticals Inc, GSK Plc, AbbVie Inc, Merck & Co Inc, and Astellas Pharma Inc are the leading players operating in the infectious diasease therapeutics market.
North America dominated the market in 2023.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Infectious Disease Therapeutics Market, by Geography (US$ Million)
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Infectious Disease Therapeutics Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Infectious Disease Therapeutics Market – Key Market Dynamics
5.1 Infectious Disease Therapeutics Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Rising Prevalence of Infectious Disease
5.2.2 Increasing Focus on Funding and R&D in Infectious Disease Therapeutics
5.3 Market Restraints
5.3.1 Emergence of Anti-infective Drugs Resistance and Associated Side Effects
5.4 Market Opportunities
5.4.1 Growing Opportunities in Developing Nations
5.5 Future Trends
5.5.1 Rising Number of Product Approvals and Launches
5.6 Impact of Drivers and Restraints:
6. Infectious Disease Therapeutics Market – Global Market Analysis
6.1 Infectious Disease Therapeutics Market Revenue (US$ Million), 2022–2030
7. Infectious Disease Therapeutics Market Analysis – by Drug Class
7.1 Overview
7.2 Anti-Viral
7.2.1 Overview
7.2.2 Anti-viral: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Anti-bacterial
7.3.1 Overview
7.3.2 Anti-bacterial: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Anti-fungal
7.4.1 Overview
7.4.2 Anti-fungal: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8. Infectious Disease Therapeutics Market Analysis – by Indication
8.1 Overview
8.2 HIV
8.2.1 Overview
8.2.2 HIV: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Hepatitis
8.3.1 Overview
8.3.2 Hepatitis: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Tuberculosis
8.4.1 Overview
8.4.2 Tuberculosis: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Influenza
8.5.1 Overview
8.5.2 Influenza: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 HPV
8.6.1 Overview
8.6.2 HPV: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
9. Infectious Disease Therapeutics Market Analysis – by Route of Administration
9.1 Overview
9.2 Oral
9.2.1 Overview
9.2.2 Oral: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Parenteral
9.3.1 Overview
9.3.2 Parenteral: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Topical
9.4.1 Overview
9.4.2 Topical: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
10. Infectious Disease Therapeutics Market Analysis – by Distribution Channel
10.1 Overview
10.2 Hospital Pharmacies
10.2.1 Overview
10.2.2 Hospital Pharmacies: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
10.3 Retail Pharmacies
10.3.1 Overview
10.3.2 Retail Pharmacies: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Others
10.4.1 Overview
10.4.2 Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11. Infectious Disease Therapeutics Market – Geographical Analysis
11.1 North America: Infectious Disease Therapeutics Market
11.1.1 Overview
11.1.2 North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.2.1 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Drug Class
11.1.2.2 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Indication
11.1.2.3 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Route of Administration
11.1.2.4 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Distribution Channel
11.1.3 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.1.3.1 North America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.1.3.2 United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.2.1 Overview
11.1.3.3 United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.3.1 United States: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.1.3.3.2 United States: Infectious Disease Therapeutics Market Breakdown, by Indication
11.1.3.3.3 United States: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.1.3.3.4 United States: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.1.3.4 Canada: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.4.1 Overview
11.1.3.5 Canada: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.5.1 Canada: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.1.3.5.2 Canada: Infectious Disease Therapeutics Market Breakdown, by Indication
11.1.3.5.3 Canada: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.1.3.5.4 Canada: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.1.3.6 Mexico: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.6.1 Overview
11.1.3.7 Mexico: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3.7.1 Mexico: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.1.3.7.2 Mexico: Infectious Disease Therapeutics Market Breakdown, by Indication
11.1.3.7.3 Mexico: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.1.3.7.4 Mexico: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2 Europe: Infectious Disease Therapeutics Market
11.2.1 Overview
11.2.2 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.2.1 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Drug Class
11.2.2.2 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Indication
11.2.2.3 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Route of Administration
11.2.2.4 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Distribution Channel
11.2.3 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.2.3.1 Europe: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.2.3.2 Germany: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.2.1 Overview
11.2.3.3 Germany: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.3.1 Germany: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.3.2 Germany: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.3.3 Germany: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.2.3.3.4 Germany: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2.3.4 United Kingdom: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.4.1 Overview
11.2.3.5 United Kingdom: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.5.1 United Kingdom: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.5.2 United Kingdom: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.5.3 United Kingdom: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.2.3.5.4 United Kingdom: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2.3.6 France: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.6.1 Overview
11.2.3.7 France: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.7.1 France: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.7.2 France: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.7.3 France: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.2.3.7.4 France: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2.3.8 Italy: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.8.1 Overview
11.2.3.9 Italy: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.9.1 Italy: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.9.2 Italy: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.9.3 Italy: Infectious Disease Therapeutics Market Breakdown, by Route Of Administration
11.2.3.9.4 Italy: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2.3.10 Spain: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.10.1 Overview
11.2.3.11 Spain: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.11.1 Spain: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.11.2 Spain: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.11.3 Spain: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.2.3.11.4 Spain: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.2.3.12 Rest of Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.12.1 Overview
11.2.3.13 Rest of Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3.13.1 Rest of Europe: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.2.3.13.2 Rest of Europe: Infectious Disease Therapeutics Market Breakdown, by Indication
11.2.3.13.3 Rest of Europe: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.2.3.13.4 Rest of Europe: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3 Asia Pacific: Infectious Disease Therapeutics Market
11.3.1 Overview
11.3.2 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.2.1 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Drug Class
11.3.2.2 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Indication
11.3.2.3 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Route Of Administration
11.3.2.4 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Distribution Channel
11.3.3 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.3.3.1 Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.3.3.2 China: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.2.1 Overview
11.3.3.3 China: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.3.1 China: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.3.2 China: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.3.3 China: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.3.3.3.4 China: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3.3.4 Japan: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.4.1 Overview
11.3.3.5 Japan: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.5.1 Japan: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.5.2 Japan: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.5.3 Japan: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.3.3.5.4 Japan: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3.3.6 India: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.6.1 Overview
11.3.3.7 India: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.7.1 India: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.7.2 India: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.7.3 India: Infectious Disease Therapeutics Market Breakdown, by Route Of Administration
11.3.3.7.4 India: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3.3.8 Australia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.8.1 Overview
11.3.3.9 Australia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.9.1 Australia: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.9.2 Australia: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.9.3 Australia: Infectious Disease Therapeutics Market Breakdown, by Route Of Administration
11.3.3.9.4 Australia: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3.3.10 South Korea: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.10.1 Overview
11.3.3.11 South Korea: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.11.1 South Korea: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.11.2 South Korea: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.11.3 South Korea: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.3.3.11.4 South Korea: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.3.3.12 Rest of APAC: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.12.1 Overview
11.3.3.13 Rest of APAC: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3.13.1 Rest of APAC: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.3.3.13.2 Rest of APAC: Infectious Disease Therapeutics Market Breakdown, by Indication
11.3.3.13.3 Rest of APAC: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.3.3.13.4 Rest of APAC: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.4 Middle East & Africa Infectious Disease Therapeutics Market
11.4.1 Overview
11.4.2 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.2.1 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Drug Class
11.4.2.2 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Indication
11.4.2.3 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Route of Administration
11.4.2.4 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Distribution Channel
11.4.3 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.4.3.1 Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.4.3.2 South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.2.1 Overview
11.4.3.3 Saudi Arabia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.3.1 Saudi Arabia: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.4.3.3.2 Saudi Arabia: Infectious Disease Therapeutics Market Breakdown, by Indication
11.4.3.3.3 Saudi Arabia: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.4.3.3.4 Saudi Arabia: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.4.3.4 South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.4.1 Overview
11.4.3.5 South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.5.1 South Africa: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.4.3.5.2 South Africa: Infectious Disease Therapeutics Market Breakdown, by Indication
11.4.3.5.3 South Africa: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.4.3.5.4 South Africa: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.4.3.6 United Arab Emirates: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.6.1 Overview
11.4.3.7 United Arab Emirates: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.7.1 United Arab Emirates: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.4.3.7.2 United Arab Emirates: Infectious Disease Therapeutics Market Breakdown, by Indication
11.4.3.7.3 United Arab Emirates: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.4.3.7.4 United Arab Emirates: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.4.3.8 Rest of Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.8.1 Overview
11.4.3.9 Rest of Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3.9.1 Rest of Middle East and Africa: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.4.3.9.2 Rest of Middle East and Africa: Infectious Disease Therapeutics Market Breakdown, by Indication
11.4.3.9.3 Rest of Middle East and Africa: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.4.3.9.4 Rest of Middle East and Africa: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.5 South and Central America: Infectious Disease Therapeutics Market
11.5.1 Overview
11.5.2 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.2.1 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Drug Class
11.5.2.2 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Indication
11.5.2.3 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Route of Administration
11.5.2.4 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Distribution Channel
11.5.3 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.5.3.1 South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast Analysis – by Country
11.5.3.2 Brazil: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.2.1 Overview
11.5.3.3 Brazil: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.3.1 Brazil: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.5.3.3.2 Brazil: Infectious Disease Therapeutics Market Breakdown, by Indication
11.5.3.3.3 Brazil: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.5.3.3.4 Brazil: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.5.3.4 Argentina: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.4.1 Overview
11.5.3.5 Argentina: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.5.1 Argentina: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.5.3.5.2 Argentina: Infectious Disease Therapeutics Market Breakdown, by Indication
11.5.3.5.3 Argentina: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.5.3.5.4 Argentina: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
11.5.3.6 Rest of South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.6.1 Overview
11.5.3.7 Rest of South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3.7.1 Rest of South and Central America: Infectious Disease Therapeutics Market Breakdown, by Drug Class
11.5.3.7.2 Rest of South and Central America: Infectious Disease Therapeutics Market Breakdown, by Indication
11.5.3.7.3 Rest of South and Central America: Infectious Disease Therapeutics Market Breakdown, by Route of Administration
11.5.3.7.4 Rest of South and Central America: Infectious Disease Therapeutics Market Breakdown, by Distribution Channel
12. Infectious Disease Therapeutics Market-Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Infectious Disease Therapeutics Market
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Pfizer Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Gilead Sciences Inc
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 F. Hoffmann-La Roche Ltd
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Shionogi & Co Ltd
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bayer AG
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 BioCryst Pharmaceuticals Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 GSK Plc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AbbVie Inc
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Merck & Co Inc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Astellas Pharma Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
List of Tables
Table 1. Infectious Disease Therapeutics Market Segmentation
Table 2. Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million) – by Drug Class
Table 3. Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million) – by Indication
Table 4. Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million) – by Route of Administration
Table 5. Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million) – by Distribution Channel
Table 6. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 7. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 8. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 9. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 10. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 11. United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 12. United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 13. United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 14. United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 15. Canada: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 16. Canada: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 17. Canada: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 18. Canada: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 19. Mexico: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 20. Mexico: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 21. Mexico: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 22. Mexico: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 23. Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 24. Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 25. Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 26. Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 27. Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 28. Germany: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 29. Germany: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 30. Germany: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 31. Germany: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 32. United Kingdom: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 33. United Kingdom: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 34. United Kingdom: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 35. United Kingdom: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 36. France: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 37. France: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 38. France: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 39. France: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 40. Italy: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 41. Italy: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 42. Italy: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 43. Italy: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 44. Spain: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 45. Spain: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 46. Spain: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 47. Spain: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 48. Rest of Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 49. Rest of Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 50. Rest of Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 51. Rest of Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 52. Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 53. Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 54. Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 55. Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 56. Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 57. China: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 58. China: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 59. China: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 60. China: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 61. Japan: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 62. Japan: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 63. Japan: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 64. Japan: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 65. India: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 66. India: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 67. India: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 68. India: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 69. Australia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 70. Australia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 71. Australia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route Of Administration
Table 72. Australia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 73. South Korea: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 74. South Korea: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 75. South Korea: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 76. South Korea: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 77. Rest of APAC: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 78. Rest of APAC: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 79. Rest of APAC: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 80. Rest of APAC: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 81. Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 82. Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 83. Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 84. Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 85. Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 86. Saudi Arabia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 87. Saudi Arabia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 88. Saudi Arabia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 89. Saudi Arabia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 90. South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 91. South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 92. South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 93. South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 94. United Arab Emirates: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 95. United Arab Emirates: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 96. United Arab Emirates: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 97. United Arab Emirates: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 98. Rest of Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 99. Rest of Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 100. Rest of Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 101. Rest of Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 102. South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 103. South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 104. South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 105. South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 106. South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Country
Table 107. Brazil: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 108. Brazil: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 109. Brazil: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 110. Brazil: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 111. Argentina: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 112. Argentina: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 113. Argentina: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 114. Argentina: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
Table 115. Rest of South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Drug Class
Table 116. Rest of South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Indication
Table 117. Rest of South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Route of Administration
Table 118. Rest of South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million) – by Distribution Channel
List of Figures
Figure 1. Infectious Disease Therapeutics Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Infectious Disease Therapeutics Market Revenue (US$ Million), 2022–2030
Figure 5. Global Eye Drops Market, By Geography Forecast Analysis, 2022 & 2030
Figure 6. Infectious Disease Therapeutics Market Share (%) – by Drug Class (2022 and 2030)
Figure 7. Anti-viral: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Anti-bacterial: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Anti-fungal: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Infectious Disease Therapeutics Market Share (%) – by Indication (2022 and 2030)
Figure 12. HIV: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Hepatitis: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Tuberculosis: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Influenza: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. HPV: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Infectious Disease Therapeutics Market Share (%) – by Route Of Administration (2022 and 2030)
Figure 19. Oral: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Parenteral: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Topical: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Infectious Disease Therapeutics Market Share (%) – by Distribution Channel (2022 and 2030)
Figure 24. Hospital Pharmacies: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. Retail Pharmacies: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Others: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. North America: Eye Drops Market, by Key Country – Revenue (2022) (US$ Million)
Figure 28. North America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 29. North America: Infectious Disease Therapeutics Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 30. United States: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 31. Canada: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 32. Mexico: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 33. Europe: Infectious Disease Therapeutics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 34. Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 35. Europe: Infectious Disease Therapeutics Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 36. Germany: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 37. United Kingdom: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 38. France: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 39. Italy: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 40. Spain: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 41. Rest of Europe: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 42. Asia Pacific: Eye Drops Market, by Key Country – Revenue (2022) (US$ Million)
Figure 43. Asia Pacific: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 44. Asia Pacific: Infectious Disease Therapeutics Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 45. China: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 46. Japan: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 47. India: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 48. Australia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 49. South Korea: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 50. Rest of APAC: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 51. Middle East & Africa: Infectious Disease Therapeutics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 52. Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 53. Middle East and Africa: Infectious Disease Therapeutics Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 54. Saudi Arabia: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 55. South Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 56. United Arab Emirates: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 57. Rest of Middle East and Africa: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 58. South & Central America: Infectious Disease Therapeutics Market, By Key Country – Revenue (2022) (US$ Million)
Figure 59. South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 60. South and Central America: Infectious Disease Therapeutics Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 61. Brazil: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 62. Argentina: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
Figure 63. Rest of South and Central America: Infectious Disease Therapeutics Market – Revenue and Forecast to 2030(US$ Million)
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For